nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapiprazole—Risperidone—H1F0—hematologic cancer	0.1	0.906	CrCbGaD
Dapiprazole—Risperidone—ABCB1—hematologic cancer	0.0104	0.0936	CrCbGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCR4—hematologic cancer	0.000246	0.000276	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PDGFRB—hematologic cancer	0.000246	0.000276	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—HDAC2—hematologic cancer	0.000246	0.000276	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCL2—hematologic cancer	0.000245	0.000276	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL6R—hematologic cancer	0.000245	0.000275	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—PIK3CB—hematologic cancer	0.000243	0.000274	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PDGFRA—hematologic cancer	0.000242	0.000272	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PRKCG—hematologic cancer	0.000241	0.000271	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—JAK1—hematologic cancer	0.000241	0.000271	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000241	0.000271	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CBL—hematologic cancer	0.000239	0.000269	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL3—hematologic cancer	0.000237	0.000266	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—JAK2—hematologic cancer	0.000234	0.000263	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PIK3CG—hematologic cancer	0.000234	0.000263	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—MAP2K1—hematologic cancer	0.000233	0.000262	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PTPN1—hematologic cancer	0.000233	0.000262	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—GRB2—hematologic cancer	0.000232	0.000261	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PIK3CD—hematologic cancer	0.000232	0.000261	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PDGFA—hematologic cancer	0.000231	0.00026	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PTPN11—hematologic cancer	0.00023	0.000259	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—RASGRP1—hematologic cancer	0.000229	0.000258	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—HSP90AA1—hematologic cancer	0.000228	0.000257	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SYK—hematologic cancer	0.000228	0.000257	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—KITLG—hematologic cancer	0.000228	0.000257	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000227	0.000255	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL2RA—hematologic cancer	0.000225	0.000253	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—IL2—hematologic cancer	0.000223	0.000251	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—STAT5A—hematologic cancer	0.000223	0.000251	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CREB1—hematologic cancer	0.000223	0.000251	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TERT—hematologic cancer	0.000223	0.00025	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000222	0.00025	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CDKN2B—hematologic cancer	0.000221	0.000249	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—STAT1—hematologic cancer	0.00022	0.000248	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PIK3R1—hematologic cancer	0.000219	0.000246	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCL2—hematologic cancer	0.000218	0.000245	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL6R—hematologic cancer	0.000217	0.000244	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PDGFB—hematologic cancer	0.000217	0.000244	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000214	0.000241	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CD86—hematologic cancer	0.000214	0.00024	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—JAK2—hematologic cancer	0.000213	0.000239	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TSC2—hematologic cancer	0.000212	0.000239	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—HES1—hematologic cancer	0.000211	0.000237	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NCOR1—hematologic cancer	0.00021	0.000236	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—JAK2—hematologic cancer	0.000208	0.000234	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CSF2—hematologic cancer	0.000207	0.000233	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—FGF1—hematologic cancer	0.000207	0.000233	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—MAP2K1—hematologic cancer	0.000207	0.000233	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—GRB2—hematologic cancer	0.000206	0.000232	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PIK3CD—hematologic cancer	0.000206	0.000231	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PDGFA—hematologic cancer	0.000206	0.000231	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—FOXO1—hematologic cancer	0.000204	0.00023	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—FGFR3—hematologic cancer	0.000204	0.00023	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—IL2—hematologic cancer	0.000204	0.00023	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PDGFRB—hematologic cancer	0.000204	0.000229	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—KITLG—hematologic cancer	0.000203	0.000228	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MAPK14—hematologic cancer	0.000202	0.000227	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PIK3CB—hematologic cancer	0.000202	0.000227	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PDGFRA—hematologic cancer	0.000201	0.000226	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—JAK1—hematologic cancer	0.0002	0.000225	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PRKCG—hematologic cancer	0.0002	0.000225	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ESR1—hematologic cancer	0.000198	0.000223	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—STAT5A—hematologic cancer	0.000198	0.000223	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000198	0.000222	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CDKN2B—hematologic cancer	0.000196	0.000221	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—FN1—hematologic cancer	0.000196	0.00022	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PIK3R1—hematologic cancer	0.000194	0.000219	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—BAD—hematologic cancer	0.000194	0.000218	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NFKBIA—hematologic cancer	0.000194	0.000218	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NOTCH1—hematologic cancer	0.000192	0.000216	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CD86—hematologic cancer	0.00019	0.000214	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—JAK2—hematologic cancer	0.000189	0.000212	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CD80—hematologic cancer	0.000188	0.000211	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PIK3CG—hematologic cancer	0.000188	0.000211	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—KIT—hematologic cancer	0.000188	0.000211	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—NRAS—hematologic cancer	0.000188	0.000211	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—HES1—hematologic cancer	0.000187	0.000211	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL2RA—hematologic cancer	0.000187	0.00021	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NCOR1—hematologic cancer	0.000186	0.000209	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL2—hematologic cancer	0.000185	0.000209	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TERT—hematologic cancer	0.000185	0.000208	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PTPN11—hematologic cancer	0.000184	0.000207	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—FGF1—hematologic cancer	0.000184	0.000207	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CSF2—hematologic cancer	0.000184	0.000207	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—FOXO1—hematologic cancer	0.000181	0.000204	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—IL2—hematologic cancer	0.000181	0.000204	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PDGFRB—hematologic cancer	0.000181	0.000204	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PDGFB—hematologic cancer	0.00018	0.000203	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—MAPK3—hematologic cancer	0.00018	0.000202	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PIK3CB—hematologic cancer	0.000179	0.000202	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CREB1—hematologic cancer	0.000179	0.000201	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PDGFRA—hematologic cancer	0.000178	0.000201	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—JAK1—hematologic cancer	0.000178	0.0002	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PRKCG—hematologic cancer	0.000178	0.0002	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—BRAF—hematologic cancer	0.000176	0.000198	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TSC2—hematologic cancer	0.000176	0.000198	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCL2—hematologic cancer	0.000175	0.000196	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL6R—hematologic cancer	0.000174	0.000196	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CREBBP—hematologic cancer	0.000174	0.000196	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—FGFR3—hematologic cancer	0.00017	0.000191	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MAPK14—hematologic cancer	0.000168	0.000189	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MAP2K1—hematologic cancer	0.000166	0.000187	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL2RA—hematologic cancer	0.000166	0.000187	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PIK3CD—hematologic cancer	0.000165	0.000185	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL2—hematologic cancer	0.000165	0.000185	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ESR1—hematologic cancer	0.000165	0.000185	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TERT—hematologic cancer	0.000164	0.000185	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000163	0.000184	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—FN1—hematologic cancer	0.000163	0.000183	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—KRAS—hematologic cancer	0.000161	0.000182	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—BAD—hematologic cancer	0.000161	0.000181	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NFKBIA—hematologic cancer	0.000161	0.000181	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PDGFB—hematologic cancer	0.00016	0.00018	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NOTCH1—hematologic cancer	0.000159	0.000179	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—FGF2—hematologic cancer	0.000158	0.000178	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TSC2—hematologic cancer	0.000157	0.000176	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CD80—hematologic cancer	0.000156	0.000175	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PIK3R1—hematologic cancer	0.000156	0.000175	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—KIT—hematologic cancer	0.000156	0.000175	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PIK3CG—hematologic cancer	0.000156	0.000175	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—NRAS—hematologic cancer	0.000156	0.000175	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PTPN11—hematologic cancer	0.000153	0.000172	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—JAK2—hematologic cancer	0.000151	0.00017	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—FGFR3—hematologic cancer	0.000151	0.000169	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MAPK14—hematologic cancer	0.000149	0.000168	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—MAPK3—hematologic cancer	0.000149	0.000168	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—PIK3CA—hematologic cancer	0.000148	0.000167	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CREB1—hematologic cancer	0.000148	0.000167	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MDM2—hematologic cancer	0.000148	0.000166	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—BRAF—hematologic cancer	0.000146	0.000165	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ESR1—hematologic cancer	0.000146	0.000165	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCL2—hematologic cancer	0.000145	0.000163	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL6R—hematologic cancer	0.000145	0.000163	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—FN1—hematologic cancer	0.000144	0.000162	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CREBBP—hematologic cancer	0.000144	0.000162	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MTOR—hematologic cancer	0.000144	0.000162	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PIK3CB—hematologic cancer	0.000144	0.000162	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NFKBIA—hematologic cancer	0.000143	0.000161	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—BAD—hematologic cancer	0.000143	0.000161	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NOTCH1—hematologic cancer	0.000141	0.000159	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CD80—hematologic cancer	0.000139	0.000156	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PIK3CG—hematologic cancer	0.000138	0.000156	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—KIT—hematologic cancer	0.000138	0.000156	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—NRAS—hematologic cancer	0.000138	0.000156	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MAP2K1—hematologic cancer	0.000138	0.000155	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—HRAS—hematologic cancer	0.000137	0.000154	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PIK3CD—hematologic cancer	0.000137	0.000154	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PTPN11—hematologic cancer	0.000136	0.000153	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000136	0.000152	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CDKN1B—hematologic cancer	0.000135	0.000152	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—KRAS—hematologic cancer	0.000134	0.000151	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—AKT1—hematologic cancer	0.000133	0.00015	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—MAPK3—hematologic cancer	0.000132	0.000149	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CASP3—hematologic cancer	0.000132	0.000149	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL2—hematologic cancer	0.000132	0.000148	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CREB1—hematologic cancer	0.000132	0.000148	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—IL6—hematologic cancer	0.000131	0.000148	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—FGF2—hematologic cancer	0.000131	0.000147	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—BRAF—hematologic cancer	0.00013	0.000146	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PIK3R1—hematologic cancer	0.000129	0.000145	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL2—hematologic cancer	0.000129	0.000145	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCND1—hematologic cancer	0.000129	0.000145	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL6R—hematologic cancer	0.000128	0.000144	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—JUN—hematologic cancer	0.000128	0.000144	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CREBBP—hematologic cancer	0.000128	0.000144	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—JAK2—hematologic cancer	0.000126	0.000141	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CDKN1A—hematologic cancer	0.000124	0.00014	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PTEN—hematologic cancer	0.000124	0.00014	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PIK3CA—hematologic cancer	0.000123	0.000138	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MDM2—hematologic cancer	0.000123	0.000138	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MAP2K1—hematologic cancer	0.000122	0.000138	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PIK3CD—hematologic cancer	0.000122	0.000137	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MAPK8—hematologic cancer	0.000121	0.000137	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—AKT1—hematologic cancer	0.000121	0.000136	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—PIK3CA—hematologic cancer	0.00012	0.000135	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MTOR—hematologic cancer	0.000119	0.000134	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PIK3CB—hematologic cancer	0.000119	0.000134	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	0.000119	0.000134	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—EP300—hematologic cancer	0.000118	0.000133	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	0.000116	0.000131	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—SRC—hematologic cancer	0.000115	0.00013	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	0.000115	0.000129	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—HRAS—hematologic cancer	0.000114	0.000128	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—VEGFA—hematologic cancer	0.000112	0.000126	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CDKN1B—hematologic cancer	0.000112	0.000126	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	0.000112	0.000125	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—STAT3—hematologic cancer	0.000111	0.000125	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NRAS—hematologic cancer	0.000111	0.000125	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AKT1—hematologic cancer	0.000111	0.000125	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CASP3—hematologic cancer	0.00011	0.000123	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL2—hematologic cancer	0.00011	0.000123	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	0.000109	0.000123	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL6—hematologic cancer	0.000109	0.000123	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	0.000109	0.000122	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCND1—hematologic cancer	0.000107	0.00012	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—JUN—hematologic cancer	0.000107	0.00012	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MAPK3—hematologic cancer	0.000106	0.000119	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	0.000106	0.000119	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	0.000106	0.000119	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CDKN1A—hematologic cancer	0.000103	0.000116	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MYC—hematologic cancer	0.000103	0.000116	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PTEN—hematologic cancer	0.000103	0.000116	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TGFB1—hematologic cancer	0.000103	0.000116	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	0.000101	0.000114	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MAPK8—hematologic cancer	0.000101	0.000113	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AKT1—hematologic cancer	0.000101	0.000113	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	9.94e-05	0.000112	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	9.84e-05	0.000111	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—EP300—hematologic cancer	9.83e-05	0.000111	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	9.75e-05	0.00011	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL2—hematologic cancer	9.73e-05	0.000109	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	9.68e-05	0.000109	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—SRC—hematologic cancer	9.56e-05	0.000108	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—KRAS—hematologic cancer	9.54e-05	0.000107	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	9.49e-05	0.000107	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—JUN—hematologic cancer	9.47e-05	0.000106	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	9.31e-05	0.000105	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	9.22e-05	0.000104	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	9.2e-05	0.000103	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	9.18e-05	0.000103	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	9.16e-05	0.000103	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	8.96e-05	0.000101	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	8.93e-05	0.0001	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	8.81e-05	9.9e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	8.76e-05	9.85e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EP300—hematologic cancer	8.73e-05	9.82e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MYC—hematologic cancer	8.57e-05	9.63e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	8.55e-05	9.61e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SRC—hematologic cancer	8.49e-05	9.55e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TP53—hematologic cancer	8.48e-05	9.53e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	8.27e-05	9.3e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	8.19e-05	9.21e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	8.17e-05	9.19e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	8.11e-05	9.12e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	7.92e-05	8.9e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	7.82e-05	8.8e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL6—hematologic cancer	7.76e-05	8.72e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MYC—hematologic cancer	7.61e-05	8.56e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	7.59e-05	8.54e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	7.27e-05	8.18e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	7.16e-05	8.05e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TP53—hematologic cancer	7.03e-05	7.91e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	7.03e-05	7.91e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	6.73e-05	7.57e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	6.46e-05	7.26e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL6—hematologic cancer	6.44e-05	7.24e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TP53—hematologic cancer	6.25e-05	7.03e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	5.98e-05	6.72e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	5.94e-05	6.68e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL6—hematologic cancer	5.72e-05	6.43e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	5.28e-05	5.93e-05	CbGpPWpGaD
